CDY.AX - Cellmid Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
30/06/2016
Total revenue
7,492
7,302
5,648
4,496
3,120
Cost of revenue
2,205
2,137
-
-
-
Gross profit
5,287
5,164
5,648
4,496
3,120
Operating expenses
Research development
873.485
848.473
598.48
599.605
354.881
Selling general and administrative
8,103
7,093
6,797
6,427
5,827
Total operating expenses
10,106
11,860
10,092
9,642
7,903
Operating income or loss
-4,818
-6,696
-4,444
-5,146
-4,783
Interest expense
132.211
235.043
473.274
291.173
195.914
Total other income/expenses net
1,143
968.628
1,153
945.191
1,451
Income before tax
-3,776
-5,885
-3,730
-4,435
-3,488
Income tax expense
24.112
24.112
2.43
35.597
11.045
Income from continuing operations
-3,800
-5,910
-3,733
-4,470
-3,499
Net income
-3,800
-5,910
-3,733
-4,470
-3,499
Net income available to common shareholders
-3,800
-5,910
-3,733
-4,470
-3,499
Basic EPS
-
-0.08
-0.07
-0.09
-0.08
Diluted EPS
-
-0.08
-0.07
-0.09
-0.08
Basic average shares
-
75,729
55,380
51,008
45,507
Diluted average shares
-
75,729
55,380
51,008
45,507
EBITDA
-
-5,650
-3,069
-3,987
-3,130